Skip to main content

Table 3 Immunoexpression of the ZNF 143, stratified according to histopathological type, clinical stage, histological grade of ovarian tumors and menopausal status of the study patients (“other” corresponds to stage IB and higher clinical stages of ovarian tumors)

From: Expression of zinc finger transcription factors (ZNF143 and ZNF281) in serous borderline ovarian tumors and low-grade ovarian cancers

ZNF 143 Group Arithmetic mean Standard deviation Minimum Lower quartile Median Upper quartile Maximum Mann-Whitney
U-test
Histopathological type Borderline 10.00 4.28 0.00 11.00 12.00 12.00 12.00 H = 1.7106
p = 0.7888
Clarocellulare 10.20 3.05 4.00 9.00 12.00 12.00 12.00
Endometrioidales 9.63 4.21 0.00 8.75 12.00 12.00 12.00
Mucinosum 12.00 0.00 12.00 12.00 12.00 12.00 12.00
Serosum 11.08 1.75 8.00 12.00 12.00 12.00 12.00
Stage IA 10.41 2.99 0.00 8.00 12.00 12.00 12.00 Z = 0.3527 p = 0.7243
Other 10.54 3.43 0.00 12.00 12.00 12.00 12.00
Grade G1 10.50 2.07 8.00 8.00 12.00 12.00 12.00 Z = 0.6029 p = 0.5466
G2 10.58 3.05 0.00 12.00 12.00 12.00 12.00
Menopausal status Postmenopausal 10.41 2.99 0.00 8.00 12.00 12.00 12.00 Z = 0.3527 p = 0.7243
Premenopausal 10.54 3.43 0.00 12.00 12.00 12.00 12.00